Description

Dalacin C Fosfat (Clindamycin) 150 mg/ml. 4 ml. №1

Composition

Active ingredient: Clindamycin phosphate 150 mg/ml.

Mechanism of Action

Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis, thereby exerting its bacteriostatic effect against susceptible anaerobic bacteria.

Pharmacological Properties

Dalacin C Fosfat exhibits potent activity against a wide range of aerobic and anaerobic bacteria, making it a valuable antibiotic in the treatment of serious infections.

Indications for Use

Indicated for: Treatment of serious infections caused by susceptible anaerobic bacteria, including skin and soft tissue infections, respiratory tract infections, and intra-abdominal infections.

Contraindications

Contraindications: Individuals with a history of hypersensitivity to clindamycin, lincomycin, or any component of the formulation should not use Dalacin C Fosfat.

Side Effects

Common side effects may include gastrointestinal disturbances, allergic reactions, and skin rashes. Severe colitis and Clostridium difficile-associated diarrhea have been reported with clindamycin use.

Usage Instructions

Dosage: The usual dose is 150 mg/ml administered via intramuscular or intravenous injection. Use Dalacin C Fosfat for intramuscular or intravenous administration only. Dosage and duration of treatment should be determined by a healthcare professional based on the specific infection being treated.

Benefits Compared to Analogues

Dalacin C Fosfat offers a broad spectrum of activity against both aerobic and anaerobic bacteria, providing an effective treatment option for serious infections. Its well-established efficacy and tolerability make it a preferred choice in clinical practice.

Suitable Patient Groups

Dalacin C Fosfat can be used in various patient populations, including adults, children, and the elderly. Dosage adjustments may be necessary based on individual patient characteristics and renal function.

Storage and Shelf Life

Store Dalacin C Fosfat according to the manufacturer’s instructions. Check the expiration date on the packaging and do not use the product beyond the stated shelf life.

Packaging Description

Dalacin C Fosfat is available in a 4 ml vial containing 150 mg/ml of clindamycin phosphate. Each package contains 1 vial of the product.

Clinical Evidence and Proven Effectiveness

Clindamycin has demonstrated efficacy in various clinical studies for the treatment of infections caused by susceptible bacteria. Clinical evidence supports its use in serious anaerobic infections, highlighting its role as a valuable antibiotic in clinical practice.